NHC director sells 5,500 shares at $133; holds 73,095 shares
National HealthCare Corp. (NHC) director Emil E. Hassan reported an open-market sale of 5,500 shares of common stock at $133 per share on 11/12/2025.
Rhea-AI Filing Summary
National HealthCare Corp. (NHC) director Emil E. Hassan reported an open-market sale of 5,500 shares of common stock at $133 per share on 11/12/2025. Following the transaction, he beneficially owns 73,095 shares directly.
The filing also lists multiple director option awards of 7,500 shares per grant, including examples with exercise prices of $71.64 and $96.03, with stated exercisable and expiration dates. A note clarifies that an option previously shown as [2024 Grant] was corrected here to [2025 Grant].
Positive
- None.
Negative
- None.
Insights
Routine insider sale; holdings and option labels clarified.
A company director disclosed selling 5,500 NHC shares at $133. Post-sale direct ownership stands at 73,095 shares, indicating continued equity exposure. Such Form 4 disclosures document insider trading activity and updated holdings.
The report itemizes several outstanding option grants of 7,500 shares each with specified strike prices and maturities. It also corrects a prior mislabeling by reclassifying a previously shown [2024 Grant] as a [2025 Grant]. Actual impact depends on holder activity and does not alter company fundamentals.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Shares of Common Stock | 5,500 | $133.00 | $732K |
| holding | Option to Purchase Common Stock [2021 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2022 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2023 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2024 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2025 Grant] | -- | -- | -- |
Footnotes (2)
- F1. Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form.
- F2. This grant was erroneously reflected as [2024 Grant] in a form 4 filed on May 8, 2025 and is corrected here.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NHC report?
Did the filing include stock options for the director?
Was any correction disclosed in the filing?
What is the reporting person’s role at NHC (ticker: NHC)?
AI-generated analysis. How Rhea-AI works. Not financial advice.